Skip to main content
. 2014 Apr 29;14:73. doi: 10.1186/1471-2466-14-73

Table 4.

Peak and late inspiratory and expiratory flow of the lung (PIF, LIF, PEF, LEF) during different parts of the respiratory cycle in different regions-of-interest (ROI)

PIF
Phase 1
Inspiration
 
Global ROI
Ventral ROI $/§
Middle ROI
Dorsal ROI
PEEP [mbar] V T /weight [ml/kg] Lung n Mean ± sd [ml/s] Mean ± sd [ml/s] Mean ± sd [ml/s] Mean ± sd [ml/s]
0
15
healthy
7
467.27 ± 56.69
109.87 ± 15.45
317.60 ± 34.38
298.54 ± 120.62
0
20
healthy
7
571.94 ± 100.47
126.10 ± 17.69
345.79 ± 54.36
327.13 ± 127.57
5
15
healthy
7
510.92 ± 102.16
116.04 ± 14.20
324.25 ± 73.59
334.11 ± 135.32
5
20
healthy
7
621.80 ± 85.20
129.70 ± 16.65
396.75 ± 50.78
348.89 ± 139.71
10
15
healthy
7
550.89 ± 82.35
105.82 ± 13.13
335.46 ± 48.16
339.63 ± 132.18
10
20
healthy
7
711.67 ± 104.68
123.85 ± 22.84
424.07 ± 84.16
402.98 ± 143.06
5
15
healthy
6
901.90 ± 92.06
118.94 ± 32.59
512.73 ± 81.67
283.00 ± 59.44
5
15
LAV
6
968.55 ± 64.49
158.94* ± 24.26
602.78* ± 91.51
335.89 ± 83.67
LIF
Phase 2
Inspiration
 
Global ROI
Ventral ROI $
Middle ROI
Dorsal ROI
PEEP [mbar]
V T /weight [ml/kg]
Lung
n
Mean ± sd [ml/s]
Mean ± sd [ml/s]
Mean ± sd [ml/s]
Mean ± sd [ml/s]
0
15
healthy
7
72.04 ± 16.52
10.26 ± 5.27
36.77 ± 28.00
19.03 ± 4.99
0
20
healthy
7
86.66 ± 36.51
10.80 ± 4.08
43.22 ± 24.84
17.66 ± 4.93
5
15
healthy
7
55.58 ± 23.32
5.65 ± 4.35
18.02 ± 3.12
16.05 ± 4.31
5
20
healthy
7
52.11 ± 10.05
9.50 ± 4.76
27.59 ± 15.06
10.45 ± 5.20
10
15
healthy
7
47.17 ± 16.57
7.83 ± 3.67
23.31 ± 8.22
11.93 ± 9.44
10
20
healthy
7
64.37 ± 45.81
8.69 ± 4.00
32.91 ± 5.27
18.07 ± 15.34
5
15
healthy
6
13.58 ± 2.70
4.03 ± 0.52
18.55 ± 8.65
12.72 ± 5.84
5
15
LAV
6
19.09* ± 5.14
2.82 ± 1.83
10.74* ± 5.29
13.02 ± 3.73
PEF
Phase 3
Expiration
 
Global ROI
Ventral ROI $/§
Middle ROI
Dorsal ROI
PEEP [mbar]
V T / weight [ml/kg]
Lung
n
Meann ± msd [ml/s]
Mean ± sd [ml/s]
Mean ± sd [ml/s]
Mean ± sd [ml/s]
0
15
healthy
7
-587.38 ± 86.73
-130.15 ± 21.79
-360.79 ± 60.67
-344.81 ± 140.78
0
20
healthy
7
-687.01 ± 138.84
-141.14 ± 24.29
-419.64 ± 68.85
-360.89 ± 135.22
5
15
healthy
7
-609.64 ± 164.78
-122.24 ± 16.87
-359.02 ± 71.82
-351.49 ± 156.67
5
20
healthy
7
-675.96 ± 142.03
-119.51 ± 20.03
-397.41 ± 67.45
-413.33 ± 170.68
10
15
healthy
7
-581.72 ± 119.23
-107.19 ± 13.15
-356.31 ± 53.46
-353.22 ± 127.59
10
20
healthy
7
-685.25 ± 114.72
-108.40 ± 13.30
-395.27 ± 41.11
-383.60 ± 152.15
5
15
healthy
6
-666.61 ± 62.94
-94.05 ± 12.91
-373.52 ± 74.09
-257.96 ± 47.51
5
15
LAV
6
-734.43* ± 44.74
-130.40* ± 26.63
-441.15 ± 102.11
-349.22 ± 145.95
LEF
Phase 4
Expiration
 
Global ROI
Ventral ROI $
Middle ROI §
Dorsal ROI
PEEP [mbar]
V T / weight [ml/kg]
Lung
n
Mean ± sd [ml/s]
Mean ± sd [ml/s]
Mean ± sd [ml/s]
Mean ± sd [ml/s]
0
15
healthy
7
-40.23 ± 25.65
-5.74 ± 4.36
-27.25 ± 14.37
-7.11 ± 5.85
0
20
healthy
7
-58.85 ± 30.50
-8.73 ± 4.94
-48.72 ± 19.19
-16.04 ± 7.86
5
15
healthy
7
-50.20 ± 17.22
-5.41 ± 4.37
-27.87 ± 8.07
-3.74 ± 1.78
5
20
healthy
7
-62.46 ± 37.63
-5.46 ± 2.57
-47.50 ± 13.66
-16.79 ± 10.81
10
15
healthy
7
-49.84 ± 37.89
-3.77 ± 2.04
-23.78 ± 22.54
-9.10 ± 11.72
10
20
healthy
7
-86.42 ± 27.98
-6.67 ± 3.74
-51.34 ± 15.72
-15.81 ± 5.00
5
15
healthy
6
-39.16 ± 23.89
-5.71 ± 3.26
-26.44 ± 10.16
-8.36 ± 4.09
5 15 LAV 6 -36.15 ± 27.84 -6.29 ± 2.20 -20.37 ± 16.26 -2.63* ± 1.00

PEEP: positive end-expiratory pressure. VT/weight: tidal volume per body weight. sd: standard deviation. LAV: lavage injury. Statistical analysis (two-way ANOVA): *p <0.05: comparison to condition above. ROI analysis: $p < 0.05 comparison to middle ROI, §p < 0.05 comparison to dorsal ROI.